164 related articles for article (PubMed ID: 1670506)
1. [Chemotherapy-induced emesis and serotonin antagonists].
Jantunen I; Johansson R
Duodecim; 1991; 107(14):1112-5. PubMed ID: 1670506
[No Abstract] [Full Text] [Related]
2. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
Abali H; Celik I
Cancer Invest; 2007; 25(3):135-9. PubMed ID: 17530482
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
4. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
[TBL] [Abstract][Full Text] [Related]
5. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
Goldsmith B
Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
[No Abstract] [Full Text] [Related]
6. Serotonin receptor antagonists in prophylaxis of acute and delayed emesis induced by moderately emetogenic, single-day chemotherapy: a randomized study.
Yalçin S; Tekuzman G; Baltali E; Ozişik Y; Barişta I
Am J Clin Oncol; 1999 Feb; 22(1):94-6. PubMed ID: 10025391
[TBL] [Abstract][Full Text] [Related]
7. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
Morrow GR; Hickok JT; Rosenthal SN
Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113
[TBL] [Abstract][Full Text] [Related]
8. Antiemetic therapy in managed care oncology: roundtable discussion.
Gerbino PP; Goldsmith M; Kenney JT; Lindley C; Nolte J; Quan W; Reich PR
Med Interface; 1996 Sep; Suppl C():16-35. PubMed ID: 10161507
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy.
Hesketh P
Semin Oncol; 1995 Aug; 22(4 Suppl 10):19-23. PubMed ID: 7570050
[No Abstract] [Full Text] [Related]
10. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
Cunningham RS
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
[TBL] [Abstract][Full Text] [Related]
11. Development of serotonin antagonists for the control of chemotherapy-induced emesis.
Hainsworth JD
Semin Surg Oncol; 1993; 9(3):279-84. PubMed ID: 8516617
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.
Jordan K; Hinke A; Grothey A; Voigt W; Arnold D; Wolf HH; Schmoll HJ
Support Care Cancer; 2007 Sep; 15(9):1023-33. PubMed ID: 17205281
[TBL] [Abstract][Full Text] [Related]
13. Fighting nausea in the '90s: more and better anti-emetics can help.
Saphir A
J Natl Cancer Inst; 1997 Sep; 89(17):1252-5. PubMed ID: 9293911
[No Abstract] [Full Text] [Related]
14. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
[TBL] [Abstract][Full Text] [Related]
15. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
16. Ondansetron to prevent vomiting after cancer chemotherapy.
Med Lett Drugs Ther; 1991 Jun; 33(847):63-4. PubMed ID: 1828531
[No Abstract] [Full Text] [Related]
17. 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised study.
Jantunen IT; Muhonen TT; Kataja VV; Flander MK; Teerenhovi L
Eur J Cancer; 1993; 29A(12):1669-72. PubMed ID: 8398291
[TBL] [Abstract][Full Text] [Related]
18. Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting.
Perez EA
Semin Oncol; 1995 Aug; 22(4 Suppl 10):1-2. PubMed ID: 7570049
[No Abstract] [Full Text] [Related]
19. '... setron': are 5-HT3 receptor antagonists different?
Aapro MS
Eur J Cancer; 1993; 29A(12):1655. PubMed ID: 8398287
[No Abstract] [Full Text] [Related]
20. The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis.
Neufeld SM; Newburn-Cook CV
J Neurosurg Anesthesiol; 2007 Jan; 19(1):10-7. PubMed ID: 17198095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
